Publication | Open Access

4,5-Diarylisoxazol-3-carboxylic acids: A new class of leukotriene biosynthesis inhibitors potentially targeting 5-lipoxygenase-activating protein (FLAP)

Leukotriene Biosynthesis InhibitorsMedicinal ChemistryAnti-inflammatoryOxysterolBiochemistryMedicineNatural SciencesPharmacological Agent4,5-Diarylisoxazol-3-carboxylic AcidsNew ClassAnti-cancer AgentPharmacologyDrug Discovery